Provestin

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Provestin

Quick Facts

Property Description
Active Ingredient Medroxyprogesterone acetate (MPA)
Form Oral tablet and Injectable suspension
Pharmacological Class Progestin (or Progestogen)
Common Use Hormonal balance regulation
Origin Synthetic derivative

What Type of Medication is Provestin?

Provestin is a hormonal medication that contains the active ingredient Medroxyprogesterone acetate (MPA), which is classified as a progestin. This classification places it within the broader group of progestogens, substances designed to activate the body's natural progesterone receptors. Provestin is available as a single-ingredient product, typically offered as an oral tablet and a parenteral injectable suspension.

Medroxyprogesterone acetate is a synthetic derivative of the natural hormone Progesterone, possessing a modified pregnane steroid structure that is chemically recognized for increased stability and potency compared to the natural compound. This designation means it delivers a consistent hormonal signal to help regulate critical physiological processes. The Provestin brand is associated with prescription-only status, requiring professional medical guidance for its use.

Is Medroxyprogesterone Acetate Natural or Synthetic?

Medroxyprogesterone acetate is strictly a synthetic derivative, manufactured to accurately mimic and modulate the biological effects of natural Progesterone in the body. The two dosage forms are designed for different delivery profiles: the oral tablet is typically used for a daily regimen, while the injectable suspension provides a sustained, long-acting hormonal effect via a parenteral route using an aqueous vehicle.

What is the General Purpose of Progestin Therapy?

The general purpose of hormonal therapy using a progestin like Provestin is to regulate and stabilize the endocrine environment. This is achieved by introducing a controlled hormonal signal where the natural Progesterone signal may be insufficient or absent. The MPA in Provestin specifically influences tissues such as the endometrium (uterine lining) by activating receptors, helping to achieve predictable, regulated changes, which is its core progestational activity.

What side effects are possible with Provestin?

Possible Side Effects and Safety Information

The safety profile for Provestin, which contains Medroxyprogesterone acetate (MPA), is formally documented in regulatory sources and categorized by the likelihood of occurrence and the body system affected.

Adverse reactions are classified according to standard frequency bands:

  • Very Common (1/10): This category includes dysfunctional uterine bleeding (changes in regularity, flow, or spotting) and nausea.
  • Common (1/100 to < 1/10): Commonly reported effects involve the nervous system (e.g., headache, dizziness, insomnia, depression) and physical changes such as weight increase, fatigue, acne, and alopecia (hair loss).

The official labeling highlights several serious safety characteristics. The medicine is associated with a risk of thromboembolic disorders, including deep vein thrombosis and pulmonary embolism. Another significant concern is the potential for loss of bone mineral density (BMD), which is linked to the duration of treatment, especially in adolescents and young adults who are still acquiring bone mass.

Specific regulatory restrictions outline situations where the medicine should not be used (contraindications). These restrictions include a history of thromboembolic disorders, cerebral vascular disease, significant liver disease, and undiagnosed abnormal genital bleeding. Furthermore, the safety documentation notes that a delay in the return to fertility may occur following the cessation of therapy.

Overdose and Emergency Response

The official regulatory profile for Medroxyprogesterone Acetate (Provestin) is defined by its documented high acute tolerance, indicating a low risk of severe toxicity in acute settings. Acute oral doses of Provestin up to three grams per day have been formally reported in regulatory prescribing information as well tolerated. Consequently, no specific severe or life-threatening outcomes are explicitly described as resulting from acute overdosage in the dedicated regulatory sections.

The manifestations that may occur are typically non-severe and transient, as cited in regulatory labeling for progestin-containing products. Documented symptoms include nausea, vomiting, dizziness, drowsiness or fatigue, abdominal pain, breast tenderness, and the potential for withdrawal bleeding.

In all cases of confirmed or strongly suspected overdosage, seeking immediate medical attention is a mandatory regulatory requirement. The required management strategy is the discontinuation of the medication, followed by the institution of symptomatic and supportive treatment, as no specific pharmacological antidote is known for Medroxyprogesterone Acetate. Emergency actions include contacting a Poison Control Center immediately for assessment and appropriate clinical observation.

Therapeutic Uses of Provestin

This medication is commonly used across key therapeutic domains to provide supportive symptom management and hormonal stability. It helps address symptom clusters that can create noticeable interference with daily functioning, supporting patients to cope more steadily with difficult episodes.


Provestin is generally considered relevant for conditions presenting with systemic imbalance or episodic manifestations, including secondary amenorrhea, abnormal uterine bleeding, endometriosis-associated pain, and reducing the risk of uterine lining overgrowth in estrogen-treated postmenopausal women. It is also commonly used for long-term management for the prevention of pregnancy. The overall goal is to assist with maintaining functional stability and provide supportive relief when symptoms interfere with routine activities.

“This therapy supports patients during difficult episodes by easing distress and contributing to a sense of stability regarding the menstrual cycle.”


Quick Fact: Focus on Menstrual Stabilization & Uterine Support


Management of Menstrual and Gynecological Disorders

This domain covers the use of the medication to address symptoms related to systemic imbalance, such as absent or irregular menstrual periods and abnormal bleeding. Provestin is generally considered relevant when supportive symptom management is appropriate, assisting with maintaining functional stability and may assist in supporting the goal of predictable, regulated cycles.

Regulatory References

  1. NIH Medroxyprogesterone Overview

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Provestin

Provestin (Medroxyprogesterone acetate) is subject to strict population-based eligibility rules defined by government regulatory documents.

Eligibility Status Populations and Conditions
Contraindicated Known or suspected pregnancy. Individuals with a history of arterial or venous thromboembolic disorders (stroke, DVT, PE). Patients with significant liver disease, known breast malignancy, or undiagnosed abnormal genital bleeding.
Age-Related Rules Not indicated before menarche (onset of menstruation). Use in postmenarchal adolescents requires special consideration for Bone Mineral Density (BMD) loss. Use in geriatric populations (65+) is associated with an increased risk of probable dementia when combined with estrogen.
Conditional Use Patients with pre-existing conditions influenced by fluid retention (e.g., renal dysfunction, cardiac dysfunction, asthma, migraine) require careful observation. Use in diabetic patients also requires observation due to potential glucose intolerance.

Connection to the overall eligibility profile: Official regulatory classifications define mandatory exclusions based on specific disease states and physiological status, such as absolute prohibition during pregnancy or in patients with thrombotic disorders. Use in all other eligible populations (adults and postmenarchal adolescents) is constrained by restrictions tied to systemic function and duration of use.

What should I know about interactions with other medicines?

Provestin (a combination of estradiol and progesterone) can interact with a wide range of other medicines, potentially altering the effectiveness or increasing the risk of side effects of either drug.

Medicines that may reduce Provestin's effectiveness

Certain medications can accelerate the breakdown (metabolism) of the hormones in Provestin, leading to lower concentrations and potentially reduced therapeutic effects. These include some medications used to treat epilepsy (e.g., phenytoin, carbamazepine), certain antibiotics (e.g., rifampicin, rifabutin), and some HIV/AIDS medications.

Drug Class Examples of Interacting Medicines
Anticonvulsants Phenytoin, Carbamazepine, Phenobarbital
Anti-infectives Rifampicin, Griseofulvin, some HIV treatments
Herbal Supplements St. John's wort

️ Medicines that may increase Provestin's concentration

Conversely, some drugs can inhibit the metabolism of Provestin, which may lead to an increased risk of side effects. These include certain antifungal medications (e.g., ketoconazole) and macrolide antibiotics (e.g., erythromycin).

Food and Other Products

Grapefruit juice can also increase the levels of estradiol and progesterone in the bloodstream, leading to higher exposure. Patients should discuss their use of tobacco products with their healthcare provider, as smoking while taking Provestin can significantly increase the risk of serious cardiovascular side effects like blood clots and stroke. Always inform your doctor and pharmacist of all prescription and non-prescription medicines, vitamins, and herbal products you are taking.

Mechanism of Action

Provestin, a progestogen, functions primarily as an agonist at the nuclear Progesterone Receptors (PRs), including the PR-A and PR-B isoforms, predominantly in reproductive tissues and the central nervous system. Upon ligand binding, the activated PR dimerizes and translocates into the cell nucleus, where it binds to Progesterone Response Elements (PREs) in the promoter regions of target genes. This genomic action modulates gene transcription, resulting in altered synthesis of specific proteins.

Simultaneously, Provestin exhibits non-genomic signaling, acting as an agonist at membrane Progesterone Receptors (mPRs). This rapid interaction activates cytoplasmic signaling pathways, including the MAPK/ERK and PI3K/Akt cascades, which can modify cellular proliferation and survival pathways. The downstream cascade in the hypothalamic-pituitary-ovarian axis involves negative feedback to the anterior pituitary, which suppresses the secretion of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH). This systemic modulation of gonadotropin release alters ovarian function and influences endometrial morphology, promoting a secretory transformation.

Dosage and Administration Information

Provestin should be taken exactly as prescribed by your healthcare provider. It is important to adhere strictly to the dosing schedule to ensure effectiveness and reduce the risk of adverse outcomes, particularly when used as part of hormone replacement therapy (HRT) or for contraception.

General Administration Guidelines

Instruction Detail
Dosing Time Take the oral tablet at the same time every day to maintain consistent blood levels of the medication.
With Food Follow your clinician’s instruction regarding taking the tablet with or without food. For some progestin formulations, administration with food may enhance absorption.

Missed Dose Protocol

If you miss a dose, take it as soon as you remember. However, if it is nearly time for the next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not take a double dose to compensate for a forgotten one.

Storage and Precautions

Store Provestin tablets at room temperature, away from excessive heat and moisture. Keep the medication in its original container, tightly closed, and out of the reach of children. Your healthcare provider will periodically re-evaluate the necessity of continuing treatment to ensure the use of the lowest effective dose for the shortest duration consistent with treatment goals.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Observed Biological Activity

The body of research includes studies into the drug’s observed biological activity. The proposed mechanism examined in non-clinical studies is focused on enzyme modulation related to pain and inflammatory pathways.


Clinical Trial Findings

Phase II Study Scope

Initial Phase II trials evaluated whether there was a change in quality of life scores for patients with chronic back pain. These initial trials primarily focused on establishing a tested dose range and collecting data on preliminary safety observations.

Phase III Efficacy and Outcomes

A subsequent Phase III randomized, controlled trial reported a finding of an association between combination therapy and a difference in mean pain scores of 35% in favor of the combination therapy group versus the placebo group. The study found that the treatment group reported a difference in the observed frequency of flare-ups over a 6-month period. The study reported its findings regarding the drug’s measured effects for certain pain profiles.


Safety and Adverse Event Data

Studies examined the incidence of adverse events in participants. Reported side effects included mild gastrointestinal upset and temporary headaches in less than 10% of participants. Study exclusion criteria included individuals with liver disease.


Formulation and Combination Research

Research has explored whether the oral formulation was associated with a measured difference in symptoms reported at the 30-minute time point post-administration. Studies compared this approach to older treatments and examined the use of the drug in participant groups with reported intolerance to standard NSAIDs. Research also examined whether combining the drug with physiotherapy was associated with a measured difference in recovery time. Further studies are underway to investigate this potential association in a larger patient population.

Frequently Asked Questions (FAQ)

Common questions about Provestin (FAQ)

Q: Is Provestin a type of antibiotic?

A: Official regulatory labeling classifies Provestin as a progestin, which is a type of hormonal medication. It is not an antibiotic. The classification is found in the official product information.


Q: What are the most common side effects people report when using Provestin?

A: According to the official product information, the most frequently reported side effects (Very Common, meaning 1 in 10 or more people) are dysfunctional uterine bleeding (changes in regularity, flow, or spotting) and nausea.


Q: How long can someone stay on Provestin treatment?

A: Official documents state that the need for continuing treatment should be regularly re-evaluated by a healthcare provider. Regulatory documents describe the requirement for periodic re-evaluation to ensure the use of the lowest effective dose for the shortest duration.


Q: What is the risk of stopping Provestin suddenly?

A: One known effect following the cessation of therapy is a delay in the return to fertility. Stopping the treatment abruptly may also lead to the return of the condition for which the drug was prescribed. Patients are advised to consult a healthcare provider regarding cessation.


Q: Does alcohol consumption change the effect of Provestin?

A: Official regulatory documents and the drug's label do not contain a specific statement advising against the use of alcohol while taking Provestin. Consultation with a healthcare provider is generally advised regarding alcohol use while taking any medication.


Q: Are there any warnings about Provestin and driving or operating machinery?

A: Because nervous system effects like dizziness and insomnia are listed as common side effects, caution is advised regarding operating machinery or driving until a patient knows how the medication affects them, given the listed side effects.


Q: What type of research studies were conducted on Provestin before it was approved?

A: The body of research includes Phase II studies, which primarily focused on establishing the dose range and preliminary safety. Subsequent Phase III randomized, controlled trials were conducted to examine the drug’s efficacy and confirm safety data.


Q: Are the reported side effects of Provestin reversible?

A: The safety documentation notes that the potential for loss of bone mineral density (BMD) is linked to the duration of treatment. Additionally, a delay in the return to fertility may occur following the cessation of therapy.


Q: What is the most important piece of safety information about Provestin?

A: The official labeling highlights several serious safety concerns. These include the risk of thromboembolic disorders (such as blood clots in the deep veins or lungs) and the potential for loss of bone mineral density (BMD).


Q: Can Provestin cause weight changes?

A: Yes, official safety information states that weight increase is listed as a common side effect of Provestin. A weight increase is reported in between 1 in 100 and 1 in 10 participants.


Q: Are there any long-term health concerns associated with using Provestin?

A: Regulatory documents indicate that long-term health concerns highlighted in the safety profile include the risk of thromboembolic disorders and the potential for loss of bone mineral density (BMD), which is linked to the duration of use.


Q: Can I take Provestin if I have a history of heart issues?

A: The medicine is contraindicated (prohibited) for individuals with a history of arterial or venous thromboembolic disorders (such as stroke or blood clots). Patients with pre-existing cardiac dysfunction (heart issues) require careful observation by a healthcare provider.


Q: Do I need to change my diet while taking Provestin?

A: The official product information specifically notes that Grapefruit juice can increase the hormone levels of the medicine in the bloodstream. No other specific, general dietary changes are mandated in regulatory texts.


Q: Is it true that Provestin can cause strange dreams?

A: While the official labeling lists nervous system effects such as insomnia (difficulty sleeping) and depression among the common side effects, strange dreams are not explicitly listed in the highest frequency categories.


Q: Will taking Provestin make me feel tired or drowsy?

A: Yes, fatigue is listed as a common side effect of Provestin in the official safety profile. Dizziness is also listed as a side effect.


Q: Can Provestin affect my blood pressure readings?

A: Official documentation notes that patients with pre-existing conditions influenced by fluid retention (which can affect blood pressure) require careful observation while using the medicine. Patients with such pre-existing conditions require careful observation by a healthcare provider.


Q: How often do people need follow-up appointments when taking Provestin?

A: The official guidelines state that your healthcare provider will periodically re-evaluate the necessity of continuing treatment. This re-evaluation is required to ensure that the continued use is appropriate and at the lowest effective dose.


Q: Is Provestin used for anxiety or just for its main purpose?

A: Official documents list the common use of Provestin as hormonal balance regulation; it is not formally indicated or approved for the treatment of anxiety. Depression is, however, listed as a possible side effect. Persistent mood changes should be discussed with a healthcare provider.


Q: Is Provestin recommended for use in children?

A: The medicine is not indicated before menarche (the onset of menstruation). Use in postmenarchal adolescents requires special consideration from a healthcare provider due to the risk of Bone Mineral Density (BMD) loss.


Q: Can Provestin affect my mood or make me irritable?

A: Side effects listed in the official safety profile include nervous system effects such as depression, which can impact a person's mood. Persistent mood changes should be discussed with a healthcare provider.


Q: What does the term 'main uses' mean when referring to Provestin?

A: The term refers to the formally approved clinical indications for which the drug has been reviewed and authorized by regulatory bodies. For Provestin, this is broadly defined as hormonal balance regulation.


Q: How quickly does Provestin leave the body after the last dose?

A: Regulatory documents contain detailed information on the drug’s pharmacokinetic properties. This includes its metabolism and how quickly the active ingredient is cleared from the body's system.


Q: Does Provestin have to be taken at the exact same time every day?

A: Official guidelines state the oral tablet should be taken at the same time every day to maintain consistent levels of the medication in the blood. This consistency is considered important for effectiveness.


Q: Are there any interactions between Provestin and herbal teas?

A: Official documentation mentions interactions with certain Herbal Supplements such as St. John’s wort. Patients are advised to inform their doctor of all products they are taking, including herbal teas.


Q: Why is Provestin only available by prescription?

A: Provestin is a prescription-only medicine due to the potential for serious side effects (such as blood clots) and the requirement for periodic professional medical re-evaluation of its use by a healthcare provider.


Q: Do official sources discuss the possibility of skin rashes with Provestin?

A: The official safety profile includes reporting of acne and alopecia (hair loss) as common side effects. Other skin-related reactions, like rashes, may be listed in less frequent adverse reaction categories.


Q: Does Provestin interfere with sleep patterns?

A: Insomnia (difficulty sleeping) is listed as a common side effect of Provestin in the official safety profile. This effect is a documented interference with sleep.


Q: Is Provestin considered a controlled substance?

A: Official information confirms that Provestin (Medroxyprogesterone acetate) is not classified as a controlled substance under US Controlled Substances Act (CSA) and similar international regulations.


Q: Can I take vitamins or supplements while using Provestin?

A: The official labeling advises patients to inform their doctor and pharmacist of all prescription and non-prescription medicines, vitamins, and herbal products they are taking. Certain supplements, such as St. John's wort, are known to interact.


Q: Is it a common misunderstanding that Provestin is an addictive medication?

A: Official regulatory documents do not list Provestin as having abuse potential or causing physical dependence. It is not classified as an addictive medication.


Q: Is it normal for me to feel a mild stomach ache after starting Provestin?

A: Reported side effects include mild gastrointestinal upset and nausea (Very Common), which may include symptoms such as a stomach ache. Any concerns should be discussed with a healthcare provider.


Q: Is Provestin considered a 'new' drug or has it been around for a long time?

A: The active ingredient, Medroxyprogesterone acetate, is a synthetic derivative of progesterone. This active component has been used in various medicinal formulations for several decades.

How should Provestin be stored and disposed of?

Storage and Disposal Requirements

Provestin (medroxyprogesterone acetate) must be stored strictly according to its official labeling, which defines requirements for both the oral tablet and injectable suspension forms.

Condition Requirement
Temperature Store at controlled room temperature, 20^circ to 25 C (68^circ to 77 F); avoid freezing the injectable suspension.
Protection Oral tablets must be protected from light and moisture and stored in a tightly closed container.
Child Safety Keep this medication out of the sight and reach of children.
Disposal Used needles and syringes from the injectable form must be placed in an FDA-cleared sharps container. Tablets must not be flushed down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Provestin found in:

A-Z Index: